The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
Antibody protection against flaviviruses is associated with the development of neutralizing antibodies against the viral envelope (E) protein. Prior studies with West Nile virus (WNV) identified therapeutic mouse and human monoclonal antibodies (MAbs) that recognized epitopes on domain III (DIII) of...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2010
|
| Subjects: | |
| Online Access: | https://doaj.org/article/df704f99bc524bef9b9a3a5bc6a7a1a1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|